Warning: Undefined variable $page_cluster_id in /home3/thegood9/public_html/website_70aad9ea/header.php on line 29



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 61

Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 77

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Tag Directory / CANCERSCREENING     showing 1–16 of 16   RSS



Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 161

American Cancer Society Updates Colorectal Cancer Screening Guideline: Major Changes Emphasize Blood-Based and At-Home Stool Testing

cancer - ACS researchers aim to reduce colorectal cancer deaths by offering options to improve screening participation

AI Summary: American Cancer Society revised colorectal screening guidelines, elevating at‑home stool testing and clarifying the role of blood‑based assays. Recommendations stress broader access to noninvasive stool tests while urging cautious, limited use of blood tests where appropriate, aiming to expand screening uptake without sacrificing diagnostic accuracy or overwhelming follow‑up resources.

#healthcare #publichealth #oncology #cancerscreening #healthdisparities #diagnostics

12 hrs / oncodaily

30 hrs / oncodaily

3 days / oncodaily

4 days / medicalxpress

4 days / cancer

4 days / cancer


Back to Top / Thursday, May 28, 2026, 11:21 pm / permalink 24464 / 6 stories in 2 days /

Simple blood test could lead to personalized lung cancer treatment

medicalxpress - A single blood test could help doctors predict how lung cancer patients will respond to treatment before therapy begins, researchers have found. University of Queensland-led research focused on non-small cell lung cancer (NSCLC), the most common form of t…

AI Summary: Researchers describe a circulating cell-free methylated DNA liquid biopsy that can detect and track lung cancer by reading tumor-specific methylation patterns in blood. The minimally invasive test aims to guide personalized treatment choices, enable earlier detection of recurrence, and reduce dependence on tissue biopsies—basically doing the diagnostic heavy lifting while you sip your coffee.


Blood-based lung cancer diagnostics and liquid biopsy

4 days / medicalxpress

4 days / oncodaily

7 days / nature


Policy, conferences and clinical practice shifts in lung cancer

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily


Tumor plasticity and molecular drivers of resistance

4 days / nature

4 days / medicalxpress

4 days / medicalxpress


All Other Stories

5 hrs / oncodaily

5 hrs / oncodaily

13 hrs / oncodaily

14 hrs / medicalxpress

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

4 days / medicalxpress



Adding a Lower Cutoff Value for CA19-9 May Identify Additional High-risk Cases of Pancreatic Cancer

Kathleen Medora / aacr - CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model for measuring the pancreatic tumor marker serum carbohydrate antigen 19-9 (CA19-9) identified patients with pancreatic canc…

AI Summary: Researchers propose lowering the CA19‑9 threshold to identify additional patients at high risk for pancreatic cancer. The analysis indicates the new cutoff improves detection of potentially dangerous cases without an unmanageable rise in false positives, offering a straightforward diagnostic tweak that could prompt earlier workups and treatment decisions.

#healthcare #oncology #pancreaticcancer #cancerresearch #cancerscreening #diagnostics

2 days / oncodaily

2 days / newscientist

4 days / oncodaily

10 days / medicalxpress


Back to Top / Saturday, May 23, 2026, 12:22 am / permalink 24227 / 5 stories in 8 days /

Skin cancer cases hit record high in the UK

Sydney Ghazarian / cancerresearchuk - New analysis shows that melanoma skin cancer rates in the UK have reached a new high of 20,000 cases per yearThe post Skin cancer cases hit record high in the UK appeared first on Cancer Research UK - Cancer News.

AI Summary: The UK has recorded its highest-ever number of skin cancer cases, with an alarming rise in the most dangerous presentations. Public health experts point to changing sun behaviours and inadequate sun protection as likely contributors. The surge signals strain on dermatology services and a need for clearer messaging—because sunscreen confusion apparently remains a public health hobby.

#healthcare #publichealth #oncology #hospitaloperations #cancerresearch #cancerscreening #diagnostics

5 days / bbc

6 days / medicalxpress

7 days / oncodaily

9 days / medicalxpress

10 days / medicalxpress

10 days / bbc


Back to Top / Friday, May 22, 2026, 8:22 pm / permalink 24212 / 7 stories in 9 days /

Kicking Off the Cancer Planners Forum in Geneva – UICC

oncodaily - Union for International Cancer Control (UICC) shared a post on LinkedIn: “We’re excited to kick off the Cancer Planners Forum in Geneva today! Convening national leaders responsible for cancer control planning, […]

AI Summary: The UICC Cancer Planners Forum in Geneva brought policymakers, clinicians, and public‑health leaders together to map national cancer control strategies, prioritize cervical cancer elimination, and foster implementation partnerships. The forum emphasized practical planning, stakeholder engagement, and resource‑sensitive solutions to turn plans into measurable improvements in prevention, screening, and care delivery.


Cervical cancer elimination and clinical partnerships

13 days / esmo

13 days / oncodaily

14 days / oncodaily


Forum launch and wrap-up in Geneva

15 days / oncodaily

16 days / oncodaily

18 days / oncodaily


National cancer planning and policy priorities

13 days / oncodaily

13 days / oncodaily

15 days / oncodaily


All Other Stories

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / esmo

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

2 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

3 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / medicalxpress

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / medicalxpress

4 days / oncodaily

4 days / oncodaily

4 days / medicalxpress

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / medicalxpress

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

4 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / oncodaily

5 days / esmo

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

6 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

7 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

8 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

9 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

10 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / medicalxpress

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / medicalxpress

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

11 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

12 days / oncodaily

13 days / oncodaily

13 days / esmo




Blog Post
The Union for International Cancer Control (UICC) convened the Cancer Planners Forum in Geneva, bringing together national cancer-control leaders, policymakers, clinicians and public‑health experts to advance practical planning and implementation. UICC reported 120 participants from 54 countries, including 45 cancer planners from 42 countries. Over the course of the forum — described by participants including UICC President‑Elect Zainab Shinkafi‑Bagudu, McCabe Centre’s Hayley Jones, and Pfizer’s Jennifer Young — delegates worked to map national cancer control strategies, prioritize cervical cancer elimination, and build implementation partnerships. The meeting emphasized stakeholder engagement and resource‑sensitive, operational approaches to turn plans into measurable improvements in prevention, screening and care delivery. UICC announced the forum both at its kickoff and on conclusion as a successful convening of planners and partners.

When should you get a mammogram? Conflicting advice makes it hard to know

medicalxpress - Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for age 50. They also differ on whether yearly or every other year is best.

AI Summary: Conflicting guidance about when to start and how often to perform mammography continues to confuse patients and clinicians, complicating shared decision‑making. Experts urge individualized risk assessment and clearer communication of benefits and harms to reduce both undertreatment and unnecessary anxiety, because apparently screening schedules enjoy being controversial.


Patient confusion over mammogram timing

15 days / medicalxpress

15 days / abcnews


Risk-based screening: AI and trials

8 days / nature

14 days / oncodaily


USPSTF political shake-up threatens screening guidance

11 days / abcnews


All Other Stories

3 days / bbc

3 days / bbc



National study examines genetic testing to inform follow-up care for cancer survivors

medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…

AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.


Building survivorship standards, care and advocacy

20 days / oncodaily

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily


Conferences, research and personalized cancer survivorship insights

21 days / oncodaily

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily


National genetic-testing study and genomic implications for survivors

20 days / oncodaily

20 days / medicalxpress

24 days / medicalxpress

24 days / esmo


All Other Stories

16 days / oncodaily

16 days / oncodaily

16 days / oncodaily

17 days / nature

17 days / medicalxpress

17 days / medicalxpress

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / oncodaily

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

17 days / medicalxpress

17 days / oncodaily

17 days / oncodaily

18 days / oncodaily

18 days / oncodaily

18 days / medicalxpress

18 days / oncodaily

19 days / medicalxpress

19 days / oncodaily

20 days / medicalxpress



AI, face photos may predict cancer survival: Mass General Brigham study

Giles Bruce / beckershospitalreview - Using multiple photos from across a patient’s course of treatment in the FaceAge AI tool may be an even better predictor of survival than a single photo alone, a new Mass General Brigham study found. Researchers behind FaceAge, which uses AI to analyze a …

AI Summary: An AI model trained on clinical cohorts at Mass General Brigham can estimate biological aging from simple facial photos and links accelerated facial aging to poorer cancer survival. The research suggests noninvasive image-based signals could complement standard prognostic markers, offering a surprising, low-cost way to flag higher-risk patients earlier.

#healthcare #biotech #digitalhealth #oncology #cancerresearch #cancerscreening #healthit #diagnostics

19 days / medicalxpress

20 days / medicalxpress

21 days / medicalxpress

27 days / medicalxpress

27 days / medicalxpress


Back to Top / Saturday, May 2, 2026, 1:21 am / permalink 23107 / 9 stories in 29 days /

11 cancers on the rise in young people - scientists find first clue why it's happening

bbc - Researchers stress that simple lifestyle changes can still significantly reduce the risk of cancer.

AI Summary: New studies report rising incidence of several cancers among younger adults, with England data showing increases in bowel and ovarian cancers and researchers claiming early clues to underlying drivers. Scientists are calling for urgent investigation into environmental, lifestyle, and diagnostic factors, enhanced surveillance and prevention measures — because apparently youth is no longer a guarantee.


New lab discoveries point to targeted, immune-based cancer therapies


Other health stories: infections, liver care, social impacts on youth


Prevention and screening gaps risk late diagnoses, experts warn

4 wks / bbc


Younger adults facing rising cancers — investigators hunt environmental culprits

4 wks / oncodaily

4 wks / oncodaily

4 wks / sciencedaily

4 wks / bbc

4 wks / newscientist


All Other Stories

21 days / oncodaily

22 days / oncodaily

22 days / oncodaily

22 days / oncodaily

22 days / oncodaily

23 days / nature

23 days / oncodaily

23 days / oncodaily

23 days / medicalxpress

23 days / bbc

25 days / oncodaily

26 days / oncodaily

27 days / esmo

28 days / oncodaily

28 days / oncodaily

28 days / oncodaily

28 days / oncodaily

28 days / oncodaily

29 days / oncodaily

29 days / oncodaily

29 days / oncodaily

29 days / oncodaily

4 wks / nature

4 wks / oncodaily



A machine learning model that uses DNA methylation patterns may help identify the origin of cancers of unknown primary

medicalxpress - A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research presented at the American Association for Cancer Research …

AI Summary: A machine‑learning model trained on DNA methylation signatures can assign tissue‑of‑origin for cancers of unknown primary with promising accuracy. The approach could speed diagnosis, guide therapy choices and reduce reliance on invasive tests—handy when a tumor refuses to tell doctors where it came from.


ctDNA and AI for treatment monitoring and early detection

25 days / oncodaily

29 days / oncodaily

4 wks / oncodaily


Liquid biopsies and extracellular vesicles for early cancer detection

29 days / oncodaily

29 days / medicalxpress


Methylation-based ML to identify cancers' tissue of origin


All Other Stories

23 days / nature

4 wks / oncodaily



Cancer Risk Is Significantly Higher for Adults Who Never Married, Large Study Finds

oncodaily - Analysis of 4 million cases finds higher cancer rates across most types, especially for preventable cancers. Adults who have never been married face a significantly higher risk of developing cancer […]

AI Summary: A large observational analysis found that adults who never married have a significantly higher cancer risk compared with married peers, after adjusting for common confounders. Researchers highlight social, behavioral and access‑to‑care factors as possible contributors, suggesting that relationship status may serve as a marker for targeted prevention and support interventions.


Lifestyle, sleep and fertility linked to cancer risk

6 wks / nature


Never-married adults face significantly higher cancer risk

7 wks / oncodaily


Place, education and loneliness drive cancer disparities



UCLA Researchers Develop Low-Cost Blood Test to Detect Multiple Cancers And Other Diseases From a Single Sample

oncodaily - The new method analyzes genome-wide methylation of DNA circulating in the bloodstream to detect liver, lung, ovarian and stomach cancers, as well as several non-cancer conditions. UCLA scientists have developed […]

AI Summary: Researchers at UCLA introduced a low-cost blood test capable of detecting multiple cancers and other diseases from a single sample, promising broader screening reach and earlier detection. If validated at scale, the technology could lower barriers to multi-cancer screening, reshape diagnostic pathways, and offer cheaper, simpler surveillance—assuming the usual caveats about follow-up testing and false positives.


Frontline: ctDNA and cfDNA - monitoring, screening, and reliability questions

7 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily


On location: early-detection debates, AI risk stratification and screening value

6 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily


On the ground: UCLA’s inexpensive blood test expands multi-disease detection

6 wks / oncodaily

7 wks / oncodaily


All Other Stories

6 wks / nature

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / oncodaily

6 wks / nature

6 wks / oncodaily

6 wks / oncodaily



Uveal Melanoma: ESMO–EURACAN Clinical Practice Guideline

esmo - This ESMO–EURACAN CPG provides key recommendations for the diagnosis, staging, treatment and follow-up for uveal melanoma. It includes percutaneous hepatic perfusion and tebentafusp as treatment options for metastatic disease, reflecting emerging evidence…

AI Summary: ESMO–EURACAN released a comprehensive clinical practice guideline for uveal melanoma covering diagnosis, staging, surveillance and systemic management. The guidance clarifies best practices for multidisciplinary care, risk stratification and therapeutic sequencing, aiming to standardize treatment and follow‑up for a rare but high‑risk ocular tumour.

#healthcare #pharmaceuticals #publichealth #oncology #cancerresearch #clinicaltrials #cancerscreening

6 wks / oncodaily

6 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily

1 month / oncodaily

1 month / esmo


Back to Top / Saturday, April 4, 2026, 12:21 pm / permalink 21779 / 7 stories in 1 month /

Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine

Sophie Wedekind / cancerresearchuk - The Bowelbabe Fund has raised more that £20 million and has announced the next wave of funded projects, including the Bowelbabe Vaccine.The post Bowelbabe Fund celebrates raising £20m by announcing the Bowelbabe Vaccine appeared first on Cancer Research U…

AI Summary: The Bowelbabe Fund celebrated a £20 million fundraising milestone and unveiled plans for a Bowelbabe Vaccine initiative, drawing high‑profile support. Organizers framed the cash infusion as a catalyst for prevention and research efforts, while public endorsements highlighted momentum — and the fundraising thermometer that finally stopped making them blush.

#healthcare #publichealth #biotech #oncology #healthcarefinance #cancerresearch #researchfunding #clinicaltrials #cancerscreening

7 wks / oncodaily

7 wks / oncodaily

7 wks / oncodaily

1 month / bbc


Back to Top / Saturday, April 4, 2026, 1:21 am / permalink 21769 / 5 stories in 1 month /

Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows

medicalxpress - New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a non–risk based population, including indivi…

AI Summary: A large population‑based study found organized lung cancer screening reduced mortality even in people who never smoked, demonstrating the benefits of expanded CT screening criteria and systematic outreach. The results suggest screening programs can detect lethal disease earlier across broader risk groups, prompting reconsideration of current eligibility rules.

#healthcare #publichealth #governmentpolicy #oncology #cancerresearch #cancerscreening #healthdisparities

1 month / esmo

1 month / medicalxpress

2 months / oncodaily

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / medicalxpress

2 months / esmo


Back to Top / Saturday, March 28, 2026, 12:22 am / permalink 21432 / 12 stories in 2 months /

High Cancer Burden Shifted From Urban to Rural Areas and Gap Widening

cancer - Two American Cancer Society studies highlight increase in cancer burden in rural areas

AI Summary: Recent analyses show the colorectal cancer burden has moved increasingly from urban centers to rural areas, widening disparities. Researchers attribute the shift to screening shortfalls, limited access to specialty care and socioeconomic barriers, and call for targeted screening, resource reallocation and tailored prevention efforts as rural populations face rising incidence and poorer outcomes.


Clinical trials and treatment advances

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Early-onset, prevention, and genetics

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / medicalxpress


Rural burden and access disparities

2 months / oncodaily

2 months / medicalxpress

2 months / oncodaily

2 months / oncodaily

2 months / cancer


All Other Stories

2 months / oncodaily

2 months / oncodaily

2 months / medicalxpress

2 months / medicalxpress

2 months / oncodaily



Back to Top


CANCERSCREENING Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


Warning: Undefined variable $target_date in /home3/thegood9/public_html/website_70aad9ea/tag.php on line 300

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Corporate Takeover, CDC, Cancer Screening, Avian Influenza and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.